logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12121511 B1

PDFFull Text
Date of Patent:
Oct. 22, 2024

Filed:

Jan. 27, 2021

Glp-1r modulating compounds

Applicant:

Gilead Sciences, Inc., Foster City, CA (US);

Inventors:

Stephen E. Ammann, Redwood City, CA (US);

Gediminas J. Brizgys, San Carlos, CA (US);

James S. Cassidy, Foster City, CA (US);

Elbert Chin, San Mateo, CA (US);

Chienhung Chou, Dublin, CA (US);

Jeromy J. Cottell, Redwood City, CA (US);

Chao-I Hung, Foster City, CA (US);

Kavoos Kolahdouzan, San Francisco, CA (US);

Daniel G. Shore, Redwood City, CA (US);

Suzanne M. Szewczyk, San Mateo, CA (US);

James G. Taylor, Burlingame, CA (US);

Rhiannon Thomas-Tran, San Jose, CA (US);

Nathan E. Wright, Foster City, CA (US);

Zheng-Yu Yang, Palo Alto, CA (US);

Assignee:

Gilead Sciences, Inc., Foster City, CA (US);

Attorney:

Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.

Primary Examiner:

Po-Chih Chen

Int. Cl.
CPC ...
A61K 31/4184 (2006.01); A61K 31/4192 (2006.01); A61K 31/4196 (2006.01); A61K 31/422 (2006.01); A61K 31/424 (2006.01); A61K 31/437 (2006.01); A61K 31/4439 (2006.01); A61K 31/444 (2006.01); A61K 45/06 (2006.01); C07D 405/10 (2006.01); C07D 405/14 (2006.01); C07D 409/14 (2006.01); C07D 413/10 (2006.01); C07D 471/04 (2006.01); C07D 493/04 (2006.01); C07D 493/10 (2006.01); C07D 498/04 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4184 (2013.01); A61K 31/4192 (2013.01); A61K 31/4196 (2013.01); A61K 31/422 (2013.01); A61K 31/424 (2013.01); A61K 31/437 (2013.01); A61K 31/4439 (2013.01); A61K 31/444 (2013.01); A61K 45/06 (2013.01); C07D 405/10 (2013.01); C07D 405/14 (2013.01); C07D 409/14 (2013.01); C07D 413/10 (2013.01); C07D 471/04 (2013.01); C07D 493/04 (2013.01); C07D 493/10 (2013.01); C07D 498/04 (2013.01);
Abstract

The present disclosure provides GLP-1R agonists, and compositions, methods, and kits thereof. Such compounds are generally useful for treating a GLP-1R mediated disease or condition.

Find Patent Forward Citations

Loading…